Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	K_chnl_volt-dep_EAG	KCNH1 KCNH5	1.05e-05	2	61	2	IPR003949
Domain	Myosin_head_motor_dom	MYO6 MYO10 MYO16	2.58e-04	38	61	3	IPR001609
Domain	MYOSIN_MOTOR	MYO6 MYO10 MYO16	2.58e-04	38	61	3	PS51456
Domain	Myosin_head	MYO6 MYO10 MYO16	2.58e-04	38	61	3	PF00063
Domain	MYSc	MYO6 MYO10 MYO16	2.58e-04	38	61	3	SM00242
Domain	PAS_9	KCNH1 KCNH5	4.64e-04	10	61	2	PF13426
Domain	-	HGD KCNH1 KCNH5	5.16e-04	48	61	3	2.60.120.10
Domain	RmlC-like_jellyroll	HGD KCNH1 KCNH5	6.17e-04	51	61	3	IPR014710
Domain	K_chnl_volt-dep_EAG/ELK/ERG	KCNH1 KCNH5	9.31e-04	14	61	2	IPR003938
Domain	Rib_L2_dom2	RPL8 TP53BP1	1.55e-03	18	61	2	IPR014722
Domain	-	RPL8 TP53BP1	1.55e-03	18	61	2	2.30.30.30
Domain	IQ	MYO6 MYO10 MYO16	2.36e-03	81	61	3	SM00015
Domain	PAS-assoc_C	KCNH1 KCNH5	2.77e-03	24	61	2	IPR000700
Domain	PAS	KCNH1 KCNH5	3.00e-03	25	61	2	PF00989
Domain	PAS_fold	KCNH1 KCNH5	3.00e-03	25	61	2	IPR013767
Domain	IQ_motif_EF-hand-BS	MYO6 MYO10 MYO16	3.18e-03	90	61	3	IPR000048
Domain	PAC	KCNH1 KCNH5	3.24e-03	26	61	2	IPR001610
Domain	PAC	KCNH1 KCNH5	3.24e-03	26	61	2	SM00086
Domain	PAC	KCNH1 KCNH5	3.24e-03	26	61	2	PS50113
Domain	IQ	MYO6 MYO10 MYO16	3.49e-03	93	61	3	PS50096
Domain	CNMP_BINDING_1	KCNH1 KCNH5	4.89e-03	32	61	2	PS00888
Domain	CNMP_BINDING_2	KCNH1 KCNH5	4.89e-03	32	61	2	PS00889
Domain	PAS	KCNH1 KCNH5	4.89e-03	32	61	2	SM00091
Domain	cNMP	KCNH1 KCNH5	5.50e-03	34	61	2	SM00100
Domain	PAS	KCNH1 KCNH5	5.50e-03	34	61	2	IPR000014
Domain	PAS	KCNH1 KCNH5	5.50e-03	34	61	2	PS50112
Domain	cNMP_binding	KCNH1 KCNH5	5.50e-03	34	61	2	PF00027
Domain	cNMP-bd_dom	KCNH1 KCNH5	5.83e-03	35	61	2	IPR000595
Domain	CNMP_BINDING_3	KCNH1 KCNH5	5.83e-03	35	61	2	PS50042
Domain	Ion_trans_dom	TRPC7 KCNH1 KCNH5	6.16e-03	114	61	3	IPR005821
Domain	Ion_trans	TRPC7 KCNH1 KCNH5	6.16e-03	114	61	3	PF00520
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	EPC2 IFT140 GSDME LZTR1 ERLIN2 MYO6 MYO10 GMDS GRXCR1 ALPK1 PFKL DCN TOP3B DPH6	2.39e-08	1242	61	14	30973865
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	ERLIN2 CPA5 MYO6 IFT172 INTS11 PFKL NEB RPL8 CHUK	2.71e-07	513	61	9	25798074
Pubmed	The structure of the human betaII-tryptase tetramer: fo(u)r better or worse.	TPSAB1 TPSB2	3.03e-06	2	61	2	10500112
Pubmed	Characterization of a tryptase mRNA expressed in the human basophil cell line KU812.	TPSAB1 TPSB2	3.03e-06	2	61	2	8434231
Pubmed	Cloning and characterization of a second complementary DNA for human tryptase.	TPSAB1 TPSB2	3.03e-06	2	61	2	2203827
Pubmed	Mast cell tryptase stimulates production of decorin by human testicular peritubular cells: possible role of decorin in male infertility by interfering with growth factor signaling.	TPSAB1 DCN	3.03e-06	2	61	2	21791437
Pubmed	Functional distinction of human EAG1 and EAG2 potassium channels.	KCNH1 KCNH5	3.03e-06	2	61	2	11943152
Pubmed	Characterization of two highly polymorphic human tryptase loci and comparison with a newly discovered monkey tryptase ortholog.	TPSAB1 TPSB2	3.03e-06	2	61	2	10898108
Pubmed	Roles of surface residues of intracellular domains of heag potassium channels.	KCNH1 KCNH5	3.03e-06	2	61	2	19172261
Pubmed	Human beta-tryptase is a ring-like tetramer with active sites facing a central pore.	TPSAB1 TPSB2	3.03e-06	2	61	2	9521329
Pubmed	Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family.	TPSAB1 TPSB2	3.03e-06	2	61	2	2187193
Pubmed	Structural requirements and mechanism for heparin-dependent activation and tetramerization of human betaI- and betaII-tryptase.	TPSAB1 TPSB2	3.03e-06	2	61	2	15567416
Pubmed	Human tryptases alpha and beta/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft.	TPSAB1 TPSB2	3.03e-06	2	61	2	10391906
Pubmed	The human mast cell tryptase tetramer: a fascinating riddle solved by structure.	TPSAB1 TPSB2	3.03e-06	2	61	2	10708850
Pubmed	Tryptase haplotype in mastocytosis: relationship to disease variant and diagnostic utility of total tryptase levels.	TPSAB1 TPSB2	3.03e-06	2	61	2	17449330
Pubmed	Impact of naturally forming human α/β-tryptase heterotetramers in the pathogenesis of hereditary α-tryptasemia.	TPSAB1 TPSB2	3.03e-06	2	61	2	31337736
Pubmed	ATMIN is a transcriptional regulator of both lung morphogenesis and ciliogenesis.	IFT140 IFT172 TP53BP1	7.72e-06	22	61	3	25294941
Pubmed	Asb4, Ata3, and Dcn are novel imprinted genes identified by high-throughput screening using RIKEN cDNA microarray.	SLC38A4 DCN	9.07e-06	3	61	2	11820791
Pubmed	IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300.	NCOR2 CHUK	9.07e-06	3	61	2	16382138
Pubmed	Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3.	TPSAB1 TPSB2	9.07e-06	3	61	2	9920877
Pubmed	Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations.	TPSAB1 TPSB2	9.07e-06	3	61	2	19748655
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	PTBP3 MTRF1 ERLIN2 MOSPD2 MYO6 MTR PDZD8 PFDN5 UPF1 RAB1A TOP3B FBXL4	9.45e-06	1496	61	12	32877691
Pubmed	Myo15 function is distinct from Myo6, Myo7a and pirouette genes in development of cochlear stereocilia.	MYO6 GRXCR1	1.81e-05	4	61	2	12966030
Pubmed	Vertebrate unconventional myosins.	MYO6 MYO10	1.81e-05	4	61	2	8690736
Pubmed	Proximity labeling reveals dynamic changes in the SQSTM1 protein network.	PTBP3 MYO6 MTR UPF1 RAB1A CHUK	2.18e-05	322	61	6	39098523
Pubmed	DHHC protein family targets different subsets of glioma stem cells in specific niches.	NCOR2 PIK3CA UPF1	2.70e-05	33	61	3	30658672
Pubmed	Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families.	TPSAB1 TPSB2	3.02e-05	5	61	2	10843716
Pubmed	New developments in the genetics and activation of mast cell proteases.	TPSAB1 TPSB2	4.52e-05	6	61	2	12217407
Pubmed	BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.	NRDC MYO10 MTR PFDN5 UPF1	4.90e-05	226	61	5	25900982
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	PTBP3 NCOR2 EIF2D ERLIN2 MYO6 PIK3CA UPF1 PFKL RAB1A RPL8	5.79e-05	1247	61	10	27684187
Pubmed	Tails of unconventional myosins.	MYO6 MYO10	6.32e-05	7	61	2	11212352
Pubmed	IκB kinase complex (IKK) triggers detachment-induced autophagy in mammary epithelial cells independently of the PI3K-AKT-MTORC1 pathway.	PIK3CA CHUK	6.32e-05	7	61	2	23778976
Pubmed	H19 lncRNA controls gene expression of the Imprinted Gene Network by recruiting MBD1.	SLC38A4 DCN	8.42e-05	8	61	2	24297921
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MST1R NCOR2 LZTR1 MYO10 SGSM2 INTS11 USP40 PDZD8 TOP3B	1.26e-04	1105	61	9	35748872
Pubmed	Bimodal regulation of an Elk subfamily K+ channel by phosphatidylinositol 4,5-bisphosphate.	KCNH1 KCNH5	1.35e-04	10	61	2	26503718
Pubmed	Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics.	KCNH1 KCNH5	1.35e-04	10	61	2	22855790
Pubmed	Human transcription factor protein interaction networks.	EPC2 NCOR2 ERLIN2 LDB1 ACACB MYO6 MTR UPF1 RAB1A TP53BP1	1.77e-04	1429	61	10	35140242
Pubmed	Extensive molecular differences between anterior- and posterior-half-sclerotomes underlie somite polarity and spinal nerve segmentation.	ARHGAP5 MOSPD2 RAB1A	1.80e-04	62	61	3	19463158
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	ARHGAP5 NCOR2 IFT172 UPF1 TOP3B TP53BP1	1.85e-04	475	61	6	31040226
Pubmed	Spatially distinct otic mesenchyme cells show molecular and functional heterogeneity patterns before hearing onset.	MYO6 DCN	1.97e-04	12	61	2	37720106
Pubmed	British Society of Audiology short papers meeting on experimental studies of hearing and deafness. Cambridge, United Kingdom, 22-23 September 1996. Abstracts.	MYO6 GRXCR1	1.97e-04	12	61	2	9183385
Pubmed	The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors.	TPSAB1 PFDN5 TPSB2	2.27e-04	67	61	3	22046132
Pubmed	Identification and characterization of nardilysin as a novel dimethyl H3K4-binding protein involved in transcriptional regulation.	NCOR2 NRDC	2.33e-04	13	61	2	22294699
Pubmed	SMRT derepression by the IkappaB kinase alpha: a prerequisite to NF-kappaB transcription and survival.	NCOR2 CHUK	2.33e-04	13	61	2	15494311
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	ERLIN2 ACACB LGI2 MYO6 NEB TOP3B	2.36e-04	497	61	6	36774506
Pubmed	Human variation in alcohol response is influenced by variation in neuronal signaling genes.	HGD MYO6 KCNH1 MYO16	2.37e-04	171	61	4	20201926
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	MOSPD2 MYO6 MTR PDZD8 GMDS PFDN5 UPF1 TOP3B RPL8 TP53BP1	2.44e-04	1487	61	10	33957083
Pubmed	Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair.	NCOR2 EIF2D MYO6 MYO10 UPF1	2.53e-04	321	61	5	32098917
Pubmed	Genetic Hearing Loss Overview	GSDME MYO6 GRXCR1	2.58e-04	70	61	3	20301607
Pubmed	Differential signaling mechanism for HIV-1 Nef-mediated production of IL-6 and IL-8 in human astrocytes.	PIK3CA CHUK	2.72e-04	14	61	2	26075907
Pubmed	Mutant p53 interactome identifies nardilysin as a p53R273H-specific binding partner that promotes invasion.	NRDC TP53BP1	2.72e-04	14	61	2	22653443
Pubmed	Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16.	TPSAB1 IFT140 TPSB2	3.05e-04	74	61	3	11157797
Pubmed	H19 acts as a trans regulator of the imprinted gene network controlling growth in mice.	SLC38A4 DCN	3.13e-04	15	61	2	19762426
Pubmed	Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation.	MYO6 GRIA4	4.55e-04	18	61	2	18311135
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	EPC2 MTRF1 EIF2D PIK3CA MYO10 UPF1 RAB1A FBXL4 DPH6	4.84e-04	1327	61	9	32694731
Pubmed	Constraint and divergence of global gene expression in the mammalian embryo.	LDB1 INTS11	5.08e-04	19	61	2	25871848
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	PTBP3 NCOR2 EIF2D GSDME FERMT1 UPF1	5.45e-04	582	61	6	20467437
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	KCNH1 SLC38A4 SGSM2 NEB	5.53e-04	214	61	4	22199357
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	NCOR2 EIF2D MYO6 FERMT1 INTS11 UPF1 PFKL RPL8 TP53BP1	5.57e-04	1353	61	9	29467282
Pubmed	Characterization of mouse IFT complex B.	IFT140 IFT172	5.63e-04	20	61	2	19253336
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ARHGAP5 USP45 NRDC KCNH1 MASTL PFKL IPMK TP53BP1	5.91e-04	1084	61	8	11544199
Pubmed	Identification of genes important for cutaneous function revealed by a large scale reverse genetic screen in the mouse.	MYO6 PFKL	6.22e-04	21	61	2	25340873
Pubmed	FIP200 controls the TBK1 activation threshold at SQSTM1/p62-positive condensates.	ERLIN2 UPF1 RPL8 TP53BP1	6.45e-04	223	61	4	34226595
Pubmed	NYAP: a phosphoprotein family that links PI3K to WAVE1 signalling in neurons.	PIK3CA MYO16	6.83e-04	22	61	2	21946561
Pubmed	Co-ordinated control of the ADP-heptose/ALPK1 signalling network by the E3 ligases TRAF6, TRAF2/c-IAP1 and LUBAC.	ALPK1 CHUK	6.83e-04	22	61	2	36098982
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	EPC2 NCOR2 LDB1 PFKL TOP3B TP53BP1 CHUK	7.39e-04	857	61	7	25609649
Pubmed	Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases.	USP45 USP40	7.48e-04	23	61	2	14715245
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	ERLIN2 NRDC MYO6 INTS11 MTR UPF1 PFKL RAB1A RPL8	8.06e-04	1425	61	9	30948266
Pubmed	Upregulation of imprinted genes in mice: an insight into the intensity of gene expression and the evolution of genomic imprinting.	SLC38A4 DCN	8.15e-04	24	61	2	20168089
Pubmed	The human (PEDB) and mouse (mPEDB) Prostate Expression Databases.	IFT140 NEB DCN	8.71e-04	106	61	3	11752298
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	PTBP3 ERLIN2 NRXN3 ACACB GRIA4 NEB RAB1A TOP3B CHUK	8.77e-04	1442	61	9	35575683
Pubmed	Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms.	IFT140 IFT172	8.84e-04	25	61	2	27340223
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	MYO6 UPF1 PFKL RPL8 TP53BP1 CHUK	9.44e-04	647	61	6	26618866
Pubmed	Identification by proximity labeling of novel lipidic and proteinaceous potential partners of the dopamine transporter.	USP40 MYO16	1.03e-03	27	61	2	34709416
Pubmed	Blood pressure is regulated by an alpha1D-adrenergic receptor/dystrophin signalosome.	ERLIN2 NEB	1.03e-03	27	61	2	18468998
Pubmed	Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination.	LZTR1 UPF1	1.03e-03	27	61	2	30442762
Pubmed	SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.	PTBP3 UPF1 TOP3B RPL8	1.11e-03	258	61	4	37794589
Pubmed	Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition.	NCOR2 RPL8	1.11e-03	28	61	2	19596686
Pubmed	Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone.	ACACB PIK3CA PFKL	1.16e-03	117	61	3	18996102
Pubmed	Disruption of parental-specific expression of imprinted genes in uniparental fetuses.	SLC38A4 DCN	1.19e-03	29	61	2	16987518
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ACACB MYO6 MASTL UPF1 PFKL RPL8 TP53BP1	1.22e-03	934	61	7	33916271
Pubmed	Control of developmentally primed erythroid genes by combinatorial co-repressor actions.	NCOR2 LDB1	1.28e-03	30	61	2	26593974
Pubmed	Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.	MST1R TPSAB1 PIK3CA RAB1A	1.42e-03	276	61	4	28319085
Pubmed	Ligand-dependent differences in estrogen receptor beta-interacting proteins identified in lung adenocarcinoma cells corresponds to estrogenic responses.	MYO6 RPL8	1.45e-03	32	61	2	21951318
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NCOR2 LDB1 GRIA4 UPF1 RAB1A TOP3B TP53BP1	1.45e-03	963	61	7	28671696
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	MYO6 INTS11 UPF1 RAB1A TP53BP1 DPH6	1.45e-03	704	61	6	29955894
Pubmed	RNA binding proteins co-localize with small tau inclusions in tauopathy.	ERLIN2 PFKL RAB1A RPL8	1.56e-03	283	61	4	30068389
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	PTBP3 ERLIN2 MYO6 UPF1 PFKL TOP3B	1.67e-03	724	61	6	36232890
Interaction	NEK4 interactions	ERLIN2 CPA5 MYO6 IFT172 INTS11 MTR PFKL NEB RPL8 CHUK	8.95e-06	582	61	10	int:NEK4
Cytoband	10q24-q25	LDB1 CHUK	1.04e-05	4	61	2	10q24-q25
Cytoband	14q31	GALC NRXN3	6.21e-05	9	61	2	14q31
Cytoband	Ensembl 112 genes in cytogenetic band chr2q23	EPC2 NEB	2.29e-03	53	61	2	chr2q23
Cytoband	Ensembl 112 genes in cytogenetic band chr6q16	USP45 FBXL4	2.55e-03	56	61	2	chr6q16
Cytoband	16p13.3	TPSAB1 IFT140 TPSB2	4.25e-03	244	61	3	16p13.3
GeneFamily	Intraflagellar transport proteins\|Tetratricopeptide repeat domain containing	IFT140 IFT172	1.15e-03	24	38	2	615
GeneFamily	Potassium voltage-gated channels	KCNH1 KCNH5	3.19e-03	40	38	2	274
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	MYO10 FERMT1	4.94e-03	50	38	2	1293
GeneFamily	Ubiquitin specific peptidases	USP45 USP40	6.17e-03	56	38	2	366
Coexpression	GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_DN	GSDME LGI2 GMDS GRXCR1 RAB1A TPSB2	1.16e-06	146	61	6	M452
ToppCell	Hippocampus-Neuronal-Inhibitory\|Hippocampus / BrainAtlas - Mouse McCarroll V32	NRXN3 LGI2 PIK3CA GRIA4 NEB MYO16	1.86e-07	182	61	6	b54ae650c04dfd0759c5f5e752b9bf684dd36516
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPC7 CPA5 KCNH1 SLC38A4 NEB	2.62e-06	159	61	5	4000ed0d3b7d488722bcd0042fa2ff4405aaab82
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPC7 CPA5 KCNH1 SLC38A4 NEB	2.62e-06	159	61	5	7619d0d49738dd08daf01b42664691a5323aa793
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	NRXN3 LGI2 PIK3CA GRIA4 MYO16	2.79e-06	161	61	5	b81b346309f3facbfbebd91cae4c5b33c7bd24ef
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)\|343B / Donor, Lineage, Cell class and subclass (all cells)	GSDME LDB1 FERMT1 CYP7B1 DCN	4.43e-06	177	61	5	e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	GSDME LDB1 FERMT1 CYP7B1 DCN	4.43e-06	177	61	5	43ba6f12c2fb32698a420bf799d46ac1b558f146
ToppCell	droplet-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSPAN11 LGI2 CYP7B1 GRIA4 DCN	5.21e-06	183	61	5	a253ad65673fce6cb453e709cb235ce7cbfa18b7
ToppCell	droplet-Lung-nan-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSPAN11 LGI2 CYP7B1 GRIA4 DCN	5.21e-06	183	61	5	ddc45fb591ba0ce3fa05c08051d58286a89ef835
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	ACACB ALPK1 DCN TOP3B IPMK	8.02e-06	200	61	5	0f4b8b0868bda406fe6bf01d1b722510fdfd0168
ToppCell	Biopsy_Control_(H.)-Immune-Mast_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	TPSAB1 GALC CYP7B1 MYO16 TPSB2	8.02e-06	200	61	5	64bf125e0e5652a5a638a6bb32eb109cb0d5e232
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Parm1\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	TPSAB1 FANK1 TRPC7 TPSB2	1.64e-05	111	61	4	1847dde68d349114286bc3317be6339666df4aa2
ToppCell	PBMC-Control-cDC_2\|Control / Compartment, Disease Groups and Clusters	FANK1 NRXN3 CPA5 MYO16	5.77e-05	153	61	4	4ee37266b0054f276c7a73ab9220f681b9d74c71
ToppCell	COVID-19-Mast_cells-Mast_cells\|COVID-19 / group, cell type (main and fine annotations)	TPSAB1 GALC FERMT1 TPSB2	6.22e-05	156	61	4	bc10b94673184ef384c6665b16a1209a8975a4f1
ToppCell	COVID-19-Mast_cells\|COVID-19 / group, cell type (main and fine annotations)	TPSAB1 GALC FERMT1 TPSB2	6.22e-05	156	61	4	159504d43421ee83b9ab484816333ae549c9c2fd
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TRPC7 TSPAN11 KCNH1 KCNH5	6.38e-05	157	61	4	5aee90ad7aaa65fdabc23597451da5e48db8f4e6
ToppCell	356C-Myeloid-Mast_cell\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	TPSAB1 MYO10 FERMT1 TPSB2	7.55e-05	164	61	4	b3192c443f4848e6a8afdb89c155f9ec42a154b0
ToppCell	356C-Myeloid-Mast_cell-\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	TPSAB1 MYO10 FERMT1 TPSB2	7.55e-05	164	61	4	f7288ec4daf494dae770ea6c58bead27660ccae1
ToppCell	nucseq-Immune-Hematopoietic-Granulocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TPSAB1 GALC FERMT1 TPSB2	7.73e-05	165	61	4	37615622c736e43260c38016e7c9e565ac97a3e8
ToppCell	nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TPSAB1 GALC FERMT1 TPSB2	7.73e-05	165	61	4	640bb71e74a61df2fcb01ceeabe4c493ef836b21
ToppCell	nucseq-Immune-Hematopoietic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TPSAB1 GALC FERMT1 TPSB2	7.73e-05	165	61	4	f3df74b5763130c71c0a482a3a23f6b22acc2892
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TRPC7 CPA5 KCNH1 SLC38A4	7.92e-05	166	61	4	bcdaab49bde5beba750b76fdcc3781a3c12c4fff
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TRPC7 CPA5 KCNH1 SLC38A4	7.92e-05	166	61	4	5e3b998d740b24f790fad37350d704ca0ea10b77
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-neuroepithelial-like_cells\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	USP45 LZTR1 NEB KCNH5	8.10e-05	167	61	4	e488d9c7cf4355959e3833de3bd496c13fc11b1b
ToppCell	Control-Mast_cells\|Control / group, cell type (main and fine annotations)	TPSAB1 GALC FERMT1 TPSB2	8.48e-05	169	61	4	fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTBP3 HGD NRDC MTR	8.48e-05	169	61	4	4b3a7b4a497178799b6b2f0b744f5fb752cee31a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTBP3 HGD NRDC MTR	8.48e-05	169	61	4	a4fd646b9bf87225131fca530bd6b52df9eaf489
ToppCell	Control-Mast_cells-Mast_cells\|Control / group, cell type (main and fine annotations)	TPSAB1 GALC FERMT1 TPSB2	8.68e-05	170	61	4	c80f6d29096c372da95a8407f402349ff1bb7018
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Mast_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TPSAB1 GALC MYO16 TPSB2	8.88e-05	171	61	4	ac37c80c832504986c7a201d84f4b6aff5e5f323
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TPSAB1 GALC MYO16 TPSB2	8.88e-05	171	61	4	b6502a81df4f25660f3ae4b7443a1d999df2d32b
ToppCell	mild-Myeloid-Eosinophils\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	TPSAB1 ACACB LGI2 TPSB2	8.88e-05	171	61	4	5c8198182495bda7a826e9d80aa467f4eb1094ec
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRXN3 GRIA4 PFDN5 DCN	9.29e-05	173	61	4	66f37c1437705734b20601656fa4aa1d92ca30be
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRXN3 GRIA4 PFDN5 DCN	9.29e-05	173	61	4	649b08a409095592cccf31883be69c754411280d
ToppCell	10x5'-GI_small-bowel-Mast\|GI_small-bowel / Manually curated celltypes from each tissue	TPSAB1 CYP7B1 DCN TPSB2	9.50e-05	174	61	4	e94c980b25edfd0e8598c416828801fcc00e8ead
ToppCell	10x5'-GI_small-bowel-Mast-Mast_cells\|GI_small-bowel / Manually curated celltypes from each tissue	TPSAB1 CYP7B1 DCN TPSB2	9.50e-05	174	61	4	05525bf0a2bde2be4f7c147b17a24530ce8819e0
ToppCell	facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GSDME NRXN3 LGI2 DERL3	9.50e-05	174	61	4	eb8012823b08729b462d1e5212f4873bb6b4eb1e
ToppCell	facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GSDME NRXN3 LGI2 DERL3	9.50e-05	174	61	4	32fdeeebeeeca657eac6329caad4c28ca54e4d1c
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACACB DERL3 FERMT1 MYO16	9.71e-05	175	61	4	3f1b2e23fec953148fb0711e523c463adb07dca4
ToppCell	Healthy_Control-Myeloid-Mast\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	TPSAB1 MYO10 CYP7B1 TPSB2	9.71e-05	175	61	4	ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf
ToppCell	Healthy_Control-Myeloid-Mast-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	TPSAB1 MYO10 CYP7B1 TPSB2	9.71e-05	175	61	4	eadbbcdf2aef4cee268bc70a7a2c4175d898953b
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Mast_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TPSAB1 GALC NIPSNAP3B TPSB2	1.01e-04	177	61	4	0176ffa5e66fa684d0a8264af0db8f77fc391afd
ToppCell	3'_v3-lymph-node_spleen-Mast-Mast_cell_lympho\|lymph-node_spleen / Manually curated celltypes from each tissue	TPSAB1 GALC CPA5 TPSB2	1.01e-04	177	61	4	53040dbeb18574a48e352e4bce252c7c3018762c
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRPC7 LGI2 DCN MYO16	1.04e-04	178	61	4	e86ed30652c2de70f16430f04b78789b87df4af2
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Mast_cell\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TPSAB1 MYO16 TPSB2 TP53BP1	1.04e-04	178	61	4	c6704fcd21a9d2fe45679a1d998f04213b3bf224
ToppCell	facs-Pancreas-Exocrine-18m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACACB DERL3 FERMT1 MYO16	1.06e-04	179	61	4	bbfbfb32773346080127055b5aafa36bbf7d0942
ToppCell	3'_v3-bone_marrow-Mast\|bone_marrow / Manually curated celltypes from each tissue	TPSAB1 CYP7B1 GRIA4 TPSB2	1.08e-04	180	61	4	b37ee81b792213d6595b4ec65d04bc35d83321c7
ToppCell	droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP5 MOSPD2 MYO6 MYO10	1.11e-04	181	61	4	92d44892bb15771f0ab5fe61879b204b0acbd9b3
ToppCell	5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TPSAB1 LDB1 MYO16 TPSB2	1.13e-04	182	61	4	4cd5eb13f78f4f377932c50ac2acb4ac0cd14c12
ToppCell	hematopoetic_progenitors-CD34+_MEP_2\|World / Lineage and Cell class	TPSAB1 GALC PDZD8 TPSB2	1.13e-04	182	61	4	a7e7aa10f14111a6c7ba22e0f1668dcaa124714d
ToppCell	10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TSPAN11 MYO6 FERMT1 DCN	1.15e-04	183	61	4	27a57cd8ea924420e182f3d72f5b29b00dea8fa0
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TPSAB1 GALC CYP7B1 TPSB2	1.15e-04	183	61	4	5ac38a2ce93c53f23a89faf287b81ea138560623
ToppCell	3'-Broncho-tracheal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TPSAB1 GALC MYO16 TPSB2	1.15e-04	183	61	4	8b7f9e55c21c99395c71c5ac4f5db0f6c5733ef9
ToppCell	3'_v3-lymph-node_spleen-Mast\|lymph-node_spleen / Manually curated celltypes from each tissue	TPSAB1 GALC CYP7B1 TPSB2	1.18e-04	184	61	4	83675c7a083c52fb74dc8b9d35df0ef69715f707
ToppCell	3'_v3-lymph-node_spleen-Mast-Mast_cells\|lymph-node_spleen / Manually curated celltypes from each tissue	TPSAB1 GALC CYP7B1 TPSB2	1.18e-04	184	61	4	ed266bd2d12f86e8786473e64fbcd58319cd4c2a
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRPC7 LGI2 DCN MYO16	1.20e-04	185	61	4	79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HGD TRPC7 MYO16 KCNH5	1.20e-04	185	61	4	10da5c2a92bfb3248d3f6f94a0933996326cf590
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP5 MOSPD2 MYO6 MYO10	1.23e-04	186	61	4	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TPSAB1 GALC MYO16 TPSB2	1.25e-04	187	61	4	bdcef4f3e093c3646b639a189bbe93d6f4c40f3c
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TPSAB1 GALC MYO16 TPSB2	1.25e-04	187	61	4	09348f1e8bbbca8dca885461937b9b1dd248b034
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TPSAB1 GALC MYO16 TPSB2	1.25e-04	187	61	4	0f7a42c55997e34a0d20e492e16b03e91e965335
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TPSAB1 GALC MYO16 TPSB2	1.25e-04	187	61	4	064730fa72f8637c3db3fc34d2e363d2b9a38f1d
ToppCell	10x5'-Lung-Mast\|Lung / Manually curated celltypes from each tissue	TPSAB1 GALC MYO10 TPSB2	1.25e-04	187	61	4	f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0
ToppCell	10x5'-Lung-Mast-Mast_cells\|Lung / Manually curated celltypes from each tissue	TPSAB1 GALC MYO10 TPSB2	1.25e-04	187	61	4	da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PTBP3 NRXN3 MYO6 MYO10	1.28e-04	188	61	4	e751cff2ac8fbc1487766c1871fcc5d1005286b0
ToppCell	5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TPSAB1 CYP7B1 MYO16 TPSB2	1.31e-04	189	61	4	aba941ba6ce7702418b3f470bde573d123c4aade
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TPSAB1 GALC MYO16 TPSB2	1.31e-04	189	61	4	f01158bb15df3117fae1271bf8cf8c2501422671
ToppCell	Severe_COVID-19-Epithelial-undefined_Epi\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	MST1R MYO6 DERL3 FERMT1	1.31e-04	189	61	4	8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTBP3 NRXN3 MYO10 MTR	1.33e-04	190	61	4	b3bccf4dd95e986db3cee324a6737f5fcc22e8e5
ToppCell	droplet-Lung-18m-Epithelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FANK1 TSPAN11 SLC38A4 FERMT1	1.36e-04	191	61	4	1b59f1cad6c1a6a5938afa9195164918e3ff4e86
ToppCell	5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TPSAB1 CYP7B1 MYO16 TPSB2	1.39e-04	192	61	4	690cf19e9b0b2ada80097c63eae827529aa5b6f3
ToppCell	5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TPSAB1 CYP7B1 MYO16 TPSB2	1.39e-04	192	61	4	3d6c4c5847ca1e44fa380403d25af45d5b51ee9b
ToppCell	5'-Airway_Nasal-Immune_Myeloid_mast\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TPSAB1 CYP7B1 MYO16 TPSB2	1.39e-04	192	61	4	e0412964a3ee1bf3c0ef64f9a6f20f7e7835701e
ToppCell	5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TPSAB1 CYP7B1 MYO16 TPSB2	1.39e-04	192	61	4	b5871247a5f3e970fa05b33fff21bef9d2ab5741
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TPSAB1 PFDN5 TPSB2 RPL8	1.41e-04	193	61	4	2a32f749224942974f45af5c0937609c5f2e7664
ToppCell	3'_v3-Lung-Mast\|Lung / Manually curated celltypes from each tissue	TPSAB1 GALC CYP7B1 TPSB2	1.44e-04	194	61	4	5e6eb81ddc9d5e22c1297734689f476d5a05bff6
ToppCell	droplet-Tongue-nan-3m-Epithelial-basal_cell\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNH1 PFDN5 DCN RPL8	1.44e-04	194	61	4	1eef012e53e43c4f4f6968baac3cc28727c4a9b5
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-epithelial_progenitor_cell\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO10 IFT172 FERMT1 GMDS	1.44e-04	194	61	4	46e522ca59db545d1eb0c27cd4361f19d4f8f762
ToppCell	3'_v3-Lung-Mast-Mast_cells\|Lung / Manually curated celltypes from each tissue	TPSAB1 GALC CYP7B1 TPSB2	1.44e-04	194	61	4	7b7f1714c4a9d9519c4d0e460cb87f2eb82392dd
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_granulocytic-basophil\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TPSAB1 GALC MYO10 TPSB2	1.44e-04	194	61	4	aca009b9f1f320c0a65ea16df6595d7ede0b1fda
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TPSAB1 PFDN5 TPSB2 RPL8	1.47e-04	195	61	4	1f07502597e9476345b07f9f25aeeb6c1de13013
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial-basal_cell\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNH1 SLC38A4 FERMT1 RPL8	1.47e-04	195	61	4	eaadc79f53b1cb208c6f7999925f318e1378197f
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO10 FERMT1 GMDS GRIA4	1.50e-04	196	61	4	055993612af03bff5ef73580a6402578da850df9
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HGD TPSAB1 GALC TPSB2	1.50e-04	196	61	4	bd482b7df2993d87c0997a40c4cbd34ba07910cb
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mast\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HGD TPSAB1 GALC TPSB2	1.50e-04	196	61	4	0ebf7e5a9281ec1f33dccd1f8895afd513591b91
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TSPAN11 MYO6 MYO10 DCN	1.50e-04	196	61	4	d5ed41fa111750e6b363c04cccc40a47dd774852
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial-basal_cell_of_epidermis\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNH1 SLC38A4 FERMT1 RPL8	1.50e-04	196	61	4	d4df86ce289835e76763213641989fde77935a16
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TSPAN11 MYO6 MYO10 DCN	1.50e-04	196	61	4	760885dc608c82768fe0decd63ed9fda8315f453
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO10 ALPK1 DCN MYO16	1.53e-04	197	61	4	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TPSAB1 GALC FERMT1 TPSB2	1.53e-04	197	61	4	bed8a9b73af5caee51b1232b31c24a59353658df
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TPSAB1 GALC FERMT1 TPSB2	1.53e-04	197	61	4	b7d5073d44aa1e2cb83ea8d8104c5ed662665755
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LGI2 CYP7B1 GRIA4 DCN	1.59e-04	199	61	4	0cdbedf09ec72734b86ddab3fec562e066afed92
ToppCell	Basal\|World / shred by cell class for turbinate	GSDME FERMT1 DCN RPL8	1.59e-04	199	61	4	d9fe184a7d3251f871eba3123e0127aa1a6f2949
ToppCell	Transverse-(7)_Mast_cell-(70)_Mast\|Transverse / shred on region, Cell_type, and subtype	TPSAB1 GALC MYO10 TPSB2	1.62e-04	200	61	4	aa17354c83b0967707d995e4b74e042ac211f814
ToppCell	Sigmoid-(7)_Mast_cell-(70)_Mast\|Sigmoid / shred on region, Cell_type, and subtype	TPSAB1 GALC MYO10 TPSB2	1.62e-04	200	61	4	7224ee639d56509de854203653a85ab09e6f05fe
ToppCell	Transverse-Mast_cell-Mast\|Transverse / Region, Cell class and subclass	TPSAB1 GALC MYO10 TPSB2	1.62e-04	200	61	4	0af942a33cc50da65129204976e24203320e206d
ToppCell	Transverse-Mast_cell\|Transverse / Region, Cell class and subclass	TPSAB1 GALC MYO10 TPSB2	1.62e-04	200	61	4	5e3f5349ffbcabdca3d911fbc99a46aaa56c47c4
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Mast_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TPSAB1 GALC MYO16 TPSB2	1.62e-04	200	61	4	96540be0e906bbc626049a41978be3dc051d2024
ToppCell	Sigmoid-Mast_cell\|Sigmoid / Region, Cell class and subclass	TPSAB1 GALC MYO10 TPSB2	1.62e-04	200	61	4	025125d8b9c6540d9cdeea7f0fe9c58aec2a16b0
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TPSAB1 GALC MYO16 TPSB2	1.62e-04	200	61	4	8943278190f42016ee914e584d1b6b9aeaf7c73f
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TPSAB1 GALC MYO16 TPSB2	1.62e-04	200	61	4	41d7736427494cb30a2f23722ea2b86ff308cfd8
ToppCell	Sigmoid-(7)_Mast_cell\|Sigmoid / shred on region, Cell_type, and subtype	TPSAB1 GALC MYO10 TPSB2	1.62e-04	200	61	4	bd8e0f027055bb34e99aa0e271ec3a0912f666bb
Disease	Mainzer-Saldino Disease	IFT140 IFT172	3.93e-06	2	59	2	C1849437
Disease	tryptase beta-2 measurement	TPSAB1 TPSB2	1.40e-04	9	59	2	EFO_0008306
Disease	Hereditary hearing loss and deafness	GSDME MYO6 GRXCR1 FBXL4	2.12e-04	146	59	4	cv:C0236038
Disease	Jeune thoracic dystrophy	IFT140 IFT172	2.14e-04	11	59	2	C0265275
Disease	Bipolar I disorder	TRPC7 NRXN3	2.14e-04	11	59	2	C0853193
Disease	Short Rib-Polydactyly Syndrome	IFT140 IFT172	3.02e-04	13	59	2	C0036996
Disease	Spastic Paraplegia, Hereditary	ERLIN2 CYP7B1	3.52e-04	14	59	2	C0037773
Disease	Saldino-Noonan Syndrome	IFT140 IFT172	3.52e-04	14	59	2	C0036069
Disease	Majewski Syndrome	IFT140 IFT172	3.52e-04	14	59	2	C0024507
Disease	Nonsyndromic genetic hearing loss	GSDME MYO6 GRXCR1	4.81e-04	76	59	3	cv:C5680182
Disease	facial asymmetry measurement	NRXN3 MYO10	6.58e-04	19	59	2	EFO_0009751
Disease	urticaria	TPSAB1 TPSB2	7.30e-04	20	59	2	EFO_0005531
Disease	Leber Congenital Amaurosis	IFT140 USP45	8.85e-04	22	59	2	C0339527
Disease	Nasopharyngeal carcinoma	MST1R PIK3CA	8.85e-04	22	59	2	C2931822
Disease	Glioblastoma Multiforme	LZTR1 PIK3CA TP53BP1	1.44e-03	111	59	3	C1621958
Disease	Autosomal dominant nonsyndromic hearing loss	GSDME MYO6	1.54e-03	29	59	2	cv:C5779548
Disease	Drug habituation	NRXN3 MYO6 GRIA4	1.60e-03	115	59	3	C0013170
Disease	Substance-Related Disorders	NRXN3 MYO6 GRIA4	1.60e-03	115	59	3	C0236969
Disease	Drug abuse	NRXN3 MYO6 GRIA4	1.60e-03	115	59	3	C0013146
Disease	Drug Use Disorders	NRXN3 MYO6 GRIA4	1.60e-03	115	59	3	C0013222
Disease	Drug Dependence	NRXN3 MYO6 GRIA4	1.60e-03	115	59	3	C1510472
Disease	Substance Dependence	NRXN3 MYO6 GRIA4	1.60e-03	115	59	3	C0038580
Disease	Substance Use Disorders	NRXN3 MYO6 GRIA4	1.60e-03	115	59	3	C0038586
Disease	Organic Mental Disorders, Substance-Induced	NRXN3 MYO6 GRIA4	1.60e-03	115	59	3	C0029231
Disease	Prescription Drug Abuse	NRXN3 MYO6 GRIA4	1.60e-03	115	59	3	C4316881
Disease	Substance abuse problem	NRXN3 MYO6 GRIA4	1.64e-03	116	59	3	C0740858
Disease	Polydactyly	IFT140 PIK3CA IFT172	1.68e-03	117	59	3	C0152427
Disease	cup-to-disc ratio measurement	TSPAN11 FERMT1 GMDS MYO16 DPH6	1.68e-03	430	59	5	EFO_0006939
Disease	sensorineural hearing loss (is_implicated_in)	GSDME MYO6	1.99e-03	33	59	2	DOID:10003 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
LEVVEKRYHLGDYGG	EPC2	266	Q52LR7
VKLYAHKGDAVTVYV	EIF2D	51	P41214
YLIELSKKYGVHVCG	DPH6	186	Q7L8W6
TIAYGVIELYVKLDG	GSDME	216	O60443
EYLIGGDVKSLLHIY	MASTL	111	Q96GX5
KIVHEYIGGYIFLST	FERMT1	641	Q9BQL6
VDLLGIAVGHIYYFL	DERL3	171	Q96Q80
HQEEILGRYVGKDYK	ALPK1	1056	Q96QP1
YRGAHGIIVVYDVTD	RAB1A	81	P62820
NLVDVELIYGGVKYI	ACACB	811	O00763
GHVIYEGKKGHVLSY	NCOR2	1266	Q9Y618
HTVVAYKDAIYVFGG	LZTR1	71	Q8N653
IFEGGATELYYVLKH	LDB1	131	Q86U70
EFLLEKGYEVHGIVR	GMDS	41	O60547
VFIDGHYLGGAEKIL	GRXCR1	201	A8MXD5
DELEIKAYYAGHVLG	INTS11	146	Q5TA45
HYAGRVMYDVVGAIE	MYO16	906	Q9Y6X6
EKAIHYAEVGVIGYL	CHUK	516	O15111
RKLDHYLEYGAAVLV	KCNH5	336	Q8NCM2
ALYKVHGIEYIFGSI	CPA5	356	Q8WXQ8
VSVGKHVKGYHYIIA	GRIA4	226	P48058
HVLIDVGTGYYVEKT	PFDN5	81	Q99471
YGDITIHFKYLKEGE	PDZD8	786	Q8NEN9
AKVFLIYEGYEGLVE	PFKL	46	P17858
GGLAEHKYIQVVYLH	DCN	286	P07585
GYTKVVGVFHTEYGE	NIPSNAP3B	176	Q9BS92
VELVKGYIHYVFDLG	NRXN3	921	Q9Y4C0
VKHYAGEVQYDVRGI	MYO10	546	Q9HD67
RKLDHYIEYGAAVLV	KCNH1	366	O95259
AVDFAERHGYIKGIV	RPL8	31	P62917
DEGYVYGLKHLISVL	IPMK	396	Q8NFU5
IDKIYVRTGIYHGGE	PIK3CA	351	P42336
SAVHKIEEGHIGVYY	ERLIN2	21	O94905
SHYGYEVEEVKILGK	IFT172	351	Q9UG01
YIYHKLLGHEVEDVI	UPF1	451	Q92900
YYTELDAVVLHGVKD	FBXL4	216	Q9UKA2
LEKYYVHEDLEIGAH	CYP7B1	271	O75881
GAKRYHDLDIDYIGI	GALC	181	P54803
GDVYGFLVEHYVRKE	IFT140	1376	Q96RY7
TRGYILEVYGVHFEL	HGD	196	Q93099
IIYTGYATKHVVEGL	FANK1	61	Q8TC84
EIGVIYLHGYDKEGN	MOSPD2	91	Q8NHP6
KYHLGAYTGDDVRIV	TPSAB1	191	Q15661
KYHLGAYTGDDVRIV	TPSB2	191	P20231
VVVAQLFGGSHIYKY	LGI2	291	Q8N0V4
DVIYQIHKEYLLAGA	MTR	76	Q99707
QVYYGGIEHEIRKDV	SGSM2	561	O43147
GVRKDELVHGYILVY	ARHGAP5	841	Q13017
YGEVEDELLHAYSKV	SLC38A4	391	Q969I6
GVYKHLKYEGGIHRV	MTRF1	246	O75570
GIVLVHGYYKIDAEL	TOP3B	541	O95985
DKVLYGLYGIVEHSG	USP45	726	Q70EL2
HVVGYGKYELEEDGT	NRDC	1086	O43847
GVVKGHRKESGELYY	TP53BP1	1556	Q12888
FLVELVAGVLAHVYY	TSPAN11	101	A1L157
FILFGVYGDVHRVKI	PTBP3	376	O95758
EYIYDLFSVIIHKGG	USP40	286	Q9NVE5
EEHAIKFEYIGLGAV	MST1R	876	Q04912
DHKFIENIGYVLYGV	TRPC7	641	Q9HCX4
YQKEGLGVNEVHYVD	MYO6	496	Q9UM54
DLYVKDVLGHYVGSM	NEB	671	P20929